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ABSTRACT Continuous growth and development in
plants are accomplished by meristems, groups of undifferen-
tiated cells that persist as stem cells and initiate organs. While
the structures of the apical and floral meristems in dicotyle-
donous plants have been well described, little is known about
the underlying molecular mechanisms controlling cell prolif-
eration and differentiation in these structures. We have shown
previously that the CLAVATA1 (CLV1) gene in Arabidopsis
encodes a receptor kinase-like protein that controls the size of
the apical and floral meristems. Here, we show that KAPP, a
gene encoding a kinase-associated protein phosphatase, is
expressed in apical and young floral meristems, along with
CLV1. Overexpression of KAPP mimics the clv1 mutant phe-
notype. Furthermore, CLV1 has kinase activity: it phosphor-
ylates both itself and KAPP. Finally, KAPP binds and de-
phosphorylates CLV1. We present a model where KAPP
functions as a negative regulator of the CLAVATA1 signal
transduction pathway.
Flowering plant development is characterized by the estab-
lishment and maintenance of shoot apical meristems (SAMs).
These are structures, usually at the growing tips of the plants,
that contain slowly dividing stem cells in the center that are
surrounded by more mitotically active cells that produce organ
primordia (1). In Arabidopsis, the SAM is initiated during
embryonic growth and then lies dormant until germination.
After germination, the SAM initiates leaves, branches, and
floral meristems in succession. The floral meristems then
produce sepal, petal, stamen, and carpel primordia. The SAM
and floral meristems have a similar structure, but differ in the
types of organs initiated, in the phyllotactic pattern of organ
initiation, and in ultimate meristem fate. SAMs initiate pri-
mordia in a spiral pattern and retain indeterminate growth and
meristematic activity. In contrast, f loral meristems produce
organs in a whorled pattern and are determinate—ceasing
growth after the initiation of carpels. Therefore, the control of
cell proliferation is developmentally regulated, and in addition,
cell division patterns result from communication between cells
(2).
Mutations have been isolated that disrupt meristem struc-
ture andyor function in Arabidopsis. Among these, mutations
in the CLAVATA1 (CLV1) and CLAVATA3 (CLV3) loci result
in plants with enlarged apical and floral meristems, indicating
a defect in the control of cell proliferation versus differenti-
ation in these meristems (3–7). On the basis of double mutant
phenotypes and interactions of clv1 and clv3 alleles, the CLV1
and clv3 gene products are thought to function in the same
pathway (7). A third gene, WUSCHEL (WUS; ref. 8), has
mutant phenotypes opposite those of and epistatic to clv1,
suggesting that WUS may encode a downstream component in
the CLV1 pathway.
CLV1 encodes a putative receptor kinase similar in organi-
zation and sequence to the Arabidopsis RLK5 protein, which
was isolated by its sequence similarity to protein kinases but is
of unknown function (9, 10). Both proteins contain an N-
terminal signal sequence followed by 21 tandem leucine-rich
repeats, a membrane-spanning region, and a putative cyto-
plasmic serineythreonine kinase domain. The CLV1 gene is
specifically expressed in the interior layers of the apical and
floral meristems but its RNA is not detected in organ primor-
dia (9). Therefore, CLV1 may receive a signal that regulates
cell proliferation in the meristematic regions.
The RLK5 kinase domain has been shown to autophospho-
rylate (11) and interact with a type 2C protein phosphatase,
called kinase-associated protein phosphatase (KAPP; ref. 12).
Because CLV1 and RLK5 are closely related members of a
larger gene family (9), we tested if KAPP may act in the CLV1
pathway. Here we show that the KAPP RNA expression
domain includes the region of CLV1 RNA expression and that
constitutive KAPP expression mimics clv1 mutant phenotypes.
Furthermore, KAPP interacts with the phosphorylated form
of the CLV1 kinase domain, and KAPP can dephosphorylate
CLV1 in vitro. These data suggest that KAPP may function as
a negative regulator of the CLV1 signal transduction pathway,
as well as in other signaling pathways.
MATERIALS AND METHODS
In Situ Hybridization. The entire KAPP ORF was amplified
by PCR using KAPP-1 (ATGGCGATGATAGGGATGAAC)
and KAPP-6 (TTACAGGGAAGTATCGAAATC) as prim-
ers and ligated into a TA cloning vector (Invitrogen). A single
plasmid, called pKAPP16, was sequenced to determine the
orientation of the insert. Antisense KAPP RNA probe was
synthesized using Sp6 RNA polymerase on an EcoRV-
linearized template. Synthesis of the CLV1 probe was as
described in Clark et al. (9). Tissue was fixed, sectioned,
hybridized, washed, and exposed following the procedure of
Drews et al. (13) with modifications by Sakai et al. (14).
Construction of Transgenic Plants. The KAPP gene was
amplified from a cDNA library using the following oligonu-
cleotides with BamHI sites at the ends: SKAPP1, CGGGATC-
CAGAGAAGCGAAGACGATGGCG; and SKAPP2, CGG-
GATCCCCTAACATTACAGGGAAGTATC. The resulting
PCR product was digested with BamHI and cloned into
pGEM-7zf (Promega). The sequenced insert was transferred,
using BamHI, to the caulif lower mosaic virus 35S promoter-
containing vector pCGN18 constructed by Leslie Sieburth
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
© 1997 by The National Academy of Sciences 0027-8424y97y9410467-6$2.00y0
PNAS is available online at http:yywww.pnas.org.
Abbreviations: CLV1, CLAVATA1; SAMs, shoot apical meristems;
WUS, WUSCHEL; GST, glutathione S-transferase; KAPP, kinase-
associated protein phosphatase; KI, kinase interaction; CKD, CLV1
kinase domain; AP, alkaline phosphatase.
*To whom reprint requests should be addressed. e-mail: meyerow@
cco.caltech.edu.
10467
(15). A sense construct was identified, transformed into
Agrobacterium strain ASE, and transformed into Arabidopsis
thaliana ecotype Landsberg-erecta using the vacuum infiltra-
tion method (16). Transgenic seedlings were selected on
MurashigeySkoog (Sigma)1kanamycin plates and transferred
to soil. The resulting line was called 35S::KAPP.
Construction and Purification of Fusion Proteins. Various
regions of CLV1 and KAPP were expressed as glutathione
S-transferase (GST) fusion proteins. The kinase domain of
CLV1 (corresponding to amino acids 657–980; GenBank ac-
cession number U96879) was used to make the CKD construct.
The kinase interaction domain (KI; amino acids 50–337 of
KAPP; see ref. 12) and the KI domain plus the protein
phosphatase domain (KAPP; amino acids 50–582) of the
KAPP cDNA were amplified by PCR using the following
oligonucleotides with BamHI sites engineered at each 59 end:
KD1, CGGGATCCGTAGCGATTCGTCAGATGAA; KD4,
CGGGATCCAATAGAACGAACCCAGTCTTG; KID1,
CGGGATCCGTGGGGGATTTGCAGAGACCA; KID2,
CGGGATCCTTAAGCCCCAGGAAGCGGCCAC; and
SKAPP2, as above.
The PCR products were digested with BamHI and ligated
into the BamHI site of pGEX-2TK, which encodes GST, a
thrombin cleavage site, and a heart muscle kinase site up-
stream and in frame with the BamHI site (Pharmacia). The
clv1-1 mutation, which results in a glycine to aspartic acid
change at position 856 in the CLV1 amino acid sequence (9),
was introduced into GST-CKD to make the GST-CKD1-1
construct and the conserved lysine (at position 720 of the
CLV1 amino acid sequence) was altered to a glutamic acid to
make the GST-CKDK720E construct. All mutant constructs
were made using the Chameleon Double Stranded Site Di-
rected Mutagenesis kit following the manufacturer’s instruc-
tions (Stratagene). All plasmids were verified by sequencing,
and transformed into Escherichia coli strain ADA 94 (Nova-
gen) for protein expression.
GST-fusion proteins were isolated using a modified protocol
from Chang et al. (17). E. coli cells were grown in 200 ml of
Luria–Bertani medium to approximately an OD600 0.8 and
then induced with 0.1 mM isopropyl b-D-thiogalactopyrano-
side for 2–3 hr at 37°C. The induced cells were harvested by
centrifugation, resuspended in 10 ml of lysis buffer containing
10 mM Tris (pH 7.5), 150 mM NaCl, 1 mM DTT, 0.2% Tween
20 with 10 mgyml aprotinin, 10 mgyml leupeptin, 0.50 mgyml
Pefabloc SC (Boehringer Mannheim), and 10 mgyml pepstatin
as protease inhibitors, lysed by sonication, and separated into
soluble and insoluble fractions by centrifugation. The soluble
GST-fusion proteins were purified from the supernatant using
Glutathione Sepharose 4B (Pharmacia) following the manu-
facturer’s instructions.
CLV1 Autophosphorylation and Interactions with KAPP.
The GST-CKD, GST-CKD1-1, and GST-CKDK720E fusion
proteins were assayed for autophosphorylation by incubation
in 30 ml of 20 mM Tris (pH7.5), 100 mM NaCl, 12 mM MgCl2
with 10 mCi of [g-32P]ATP for 1 hr at room temperature.
Samples were boiled in SDS loading buffer and analyzed by
SDSyPAGE. Coomassie blue-stained gels were dried and
exposed to film. CLV1 transphosphorylation was assessed by
mixing CKDK720E protein, removed from GST by thrombin
cleavage, with GST-CKD in an autophosphorylation reaction.
CKDK720E-dependent inhibition of GST-CKD autophosphor-
ylation was demonstrated by removing the CKDK720E protein
from GST by thrombin cleavage, then adding increasing
amounts of CKDK720E to GST-CKD during autophosphoryla-
tion reactions. Phosphoamino acid analysis was performed as
described by Boyle et al. (18).
GST-KI was phosphorylated with heart muscle kinase (Sig-
ma) in 20 mM Tris (pH 7.5), 100 mM NaCl, 12 mM MgCl2 with
10 mCi (1 Ci 5 37 GBq) of [g-32P]ATP, and then eluted from
the matrix by washing with 20 mM Tris (pH 7.5), 100 mM NaCl,
12 mM MgCl2, and 20 mM glutathione. The resulting super-
natant was used to probe various GST fusion proteins bound
to nitrocellulose filters as described by Stone et al. (12).
Phosphorylation dependence of the CLV1yKAPP interactions
was tested by dephosphorylating immobilized GST-CKD with
20 units of alkaline phosphatase (AP) with and without 100
mM PO42 as an inhibitor of AP. GST-CKD was washed after
phosphatase treatment and incubated with cold ATP in a
standard autophosphorylation reaction. CLV1-dependent
KAPP phosphorylation was assessed by adding GST-KAPP to
GST-CKD, GST-CKD1-1, and GST-CKDK720E during a stan-
dard autophosphorylation reaction.
GST-KAPP-dependent dephosphorylation of GST-CKD
was tested using a modified protocol from Stone et al. (12). The
GST-CKD protein, still bound to the Glutathione Sepharose
4B matrix, was allowed to autophosphorylate in the presence
of [g-32P]ATP, then washed three times in 20 mM Tris (pH7.5),
0.1% 2-mercaptoethanol. Labeled GST-CKD, still immobi-
lized on the matrix, was incubated with and without GST-
KAPP in 20 mM Tris (pH 7.5), 0.1% 2-mercaptoethanol with
either 10 mM EDTA or 10 mM MgCl2y10 mM MnCl2 for 2 hr
at room temperature.
RESULTS
KAPP Expression Patterns. We determined the pattern of
KAPP mRNA expression by in situ hybridization. Because
KAPP does not appear to cross-hybridize to any other Arabi-
dopsis DNA sequences at low stringency (R.W.W. and E.M.M.,
data not shown), the entire KAPP ORF was used to make an
antisense RNA probe that was hybridized to 8 mm sections of
wild-type and clv1-4 inflorescence tissue. In wild-type tissue,
KAPP was expressed throughout the SAM and stage 1–2
flowers (19) but appeared to be excluded from the sepal
primordia of stage 3 flowers (Fig. 1 A–D). CLV1 is expressed
in a much more restricted domain, the central cells of the SAM
and young floral meristems (ref. 9; Fig. 1E). Therefore, the
CLV1 expression domain is encompassed within that of KAPP.
Below the SAM, KAPP RNA was detected in the provascular
tissue, but not differentiated vascular or pith tissue (Fig. 1 A–C,
F). After stage 5 of flower development, KAPP RNA levels
appeared to decrease with only weak signal detected in the
stamen and carpel primordia (Fig. 1G). Later in flower
development, KAPP was expressed in the developing pollen
sacs and ovules (Fig. 1H). KAPP expression was maintained
during ovule development (Fig. 1I).
KAPP has a similar expression pattern in clv1-4 tissue as it
does in wild-type tissue. KAPP is expressed throughout the
enlarged apical and floral meristems (Fig. 1J) as well as in the
pollen sacs, ovules, and central proliferating dome of the
mature flowers (Fig. 1K). This result indicates that clv1
mutations do not dramatically affect the level or the spatial
regulation of KAPP expression. In situ hybridization of KAPP
to clv3-2 tissue results in an RNA expression pattern similar to
that in clv1-4 tissue (data not shown). All expression patterns
are specific for KAPP and not due to background, as a KAPP
sense probe gave very little signal (Fig. 1L).
KAPP Transgenic Studies. To identify possible roles of
KAPP in meristem and flower development, we constructed
transgenic lines that express the full-length KAPP cDNA under
control of the strong, constitutive 35S-caulif lower mosaic virus
promoter (20). Two independent lines exhibited a dominant,
heritable floral phenotype that cosegregated with the trans-
ferred DNA. Both lines appear similar, so only one line was
analyzed in detail.
The 35S::KAPP line has a floral phenotype reminiscent of
that caused by weak loss-of-function clv1 alleles (4). Flowers of
the transgenic plant have a small but consistent increase in the
number of carpels compared with wild type (Fig. 2 A–C). Wild
type Landsberg-erecta plants have 2.0 6 0.0 carpels per flower.
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On average, 35S::KAPP expressing plants have 0.30 6 0.105
extra carpels per flower, and plants homozygous for the weak
clv1-7 allele have 0.75 6 0.143 extra carpels relative to wild
type. The only other observed phenotypic alteration in the
35S::KAPP line was the presence of occasional petalloid
stamens in the third whorl of the flowers (data not shown).
Flowering time, apical dominance, and male and female
fertility appear normal.
CLV1 Autophosphorylation. To test for CLV1 protein ki-
nase activity, we expressed three different versions of the
CLV1 kinase domain in E. coli. The kinase domain from CLV1
was used to make a GST fusion protein, called GST-CKD.
Fusion protein was purified from E. coli and shown to auto-
phosphorylate on serine residues (Fig. 3 A and B). This CLV1
kinase activity requires Mn21 or Mg21 (data not shown). The
clv1-1 mutation results in a protein with an aspartic acid
substituted for the first glycine in box VIII of the kinase
domain (9, 21). We made the CLV1-1 form of the kinase
domain fused to GST, GST-CKD1-1, and found that it is able
to autophosphorylate but at greatly reduced levels (Fig. 3A).
When the catalytic lysine residue was changed to glutamic acid
FIG. 1. Expression of KAPP in wild-type and clv1-4 tissue. Labeled
KAPP and CLV1-specific RNA probes were used for hybridization to
sections of inflorescence meristem and floral tissue. (A–C) Serial
sections of wild type tissue showing KAPP RNA is detected throughout
the apical and young floral meristems and down the provascular tissue.
(D) Section of a wild-type stage 3 flower where KAPP expression is
reduced in sepal primordia. (E) CLV1 mRNA expression in the center
of the apical and young floral meristems only. CLV1 is not expressed
in stage 1 flowers. (F) Transverse section of the stem, below the SAM,
showing the punctate ring of KAPP expression in the provascular
tissue. (G) KAPP weak expression in the stamen and carpel primordia
of a stage 7 flower; (H) KAPP expression in the pollen sacs and carpels
of a stage 9 flower; (I) KAPP expression in the developing ovules. (J)
KAPP is expressed throughout the enlarged SAM of a clv1-4 mutant.
(K) KAPP is expressed in the central meristematic regions in mature
clv1-4 f lowers. (L) A KAPP sense probe hybridized to a wild-type
inflorescence section. All photos are combined bright-field and dark-
field exposures, with signal indicated by yellow grains. PV, provascular;
SP, sepal primordia; St, stamen, Ca, carpel; PS, pollen sac; Pl, placenta;
Ov, ovule; Si, silique wall; CM, central meristematic regions. Numbers
indicate stages of floral development (all stages according to ref. 19).
Bars 5 40 mm.
FIG. 2. 35S::KAPP phenotype. A comparison of (A) wild-type, (B)
35S::KAPP, and (C) clv1-1 siliques. (A) A typical silique from a
wild-type Landsberg-erecta f lower is composed of two fused carpels.
The 35S::KAPP line has on average 2.3 carpels per flower; panel (B)
shows a silique comprised of three fused carpels. (C) clv1 mutants have
extra carpels that fuse into a functional silique. This representative
clv1-1 f lower contains four carpels.
FIG. 3. Autophosphorylation of the CLV1 kinase domain. (A)
GST fusion-proteins containing the wild-type (lane 1), CLV1-1 (lane
2), and CKDK720E (lane 3) forms of the CLV1 kinase domain were
allowed to phosphorylate in the presence of [g-32P]ATP. (Upper) The
Coomassie blue-stained gel showing the relative amounts of fusion
protein in each lane. (Lower) The autoradiograph. (B) The wild-type
CLV1 kinase domain was allowed to autophosphorylate, then hydro-
lyzed. The products of the hydrolysis reaction were analyzed by
electrophoresis on a TLC plate. Only serine residues were phosphor-
ylated. (C) Autophosphorylation reactions containing CKDK720E
alone (lane 1), CKDK720E plus GST-CKD (lane 2), and GST-CKD
alone. (D) Increasing amounts of CKDK720E protein were added to a
constant amount of GST-CKD during autophosphorylation reactions.
The approximate molar ratios of CKDK720E:GST-CKD are 0:1 (lane
1), 1:1 (lane 2), 2:1 (lane 3), and 4:1 (lane 4). Arrow shows the position
of the full length GST-CKD protein.
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(GST-CKDK720E), the resulting protein was unable to auto-
phosphorylate (Fig. 3A).
Genetic evidence suggests that the CLV1 protein may
function as an oligomer (4, 7). The closely related RLK5 kinase
domain can undergo intermolecular phosphorylation (11), and
the rate at which GST-CKD autophosphorylates appears to be
dependent on the concentration of the fusion protein (data not
shown), suggesting a second order reaction. We therefore
tested the ability of CLV1 to transphosphorylate. The inactive
CKDK720E protein, when removed from the GST-moiety by
thrombin cleavage, could be phosphorylated in the presence of
the active GST-CKD protein (Fig. 3C). Furthermore, GST-
CKD autophosphorylation is reduced when incubated with
increasing amounts of CKDK720E (Fig. 3D). This finding indi-
cates that CLV1, like RLK5 (11), can interact intermolecularly
and undergo transphosphorylation.
CLV1yKAPP Interactions. The region of the KAPP protein
defined to be the KI domain (12) was also used to make a
GST-fusion protein, called GST-KI. The KI protein could be
labeled at an engineered heart muscle kinase site. The result-
ing GST-KI protein interacted with GST-CKD (Fig. 4A) in a
filter binding assay. GST-KI did not bind to either GST-
CKD1-1 or GST-CKDK720E at detectable levels (Fig. 4A),
suggesting that the introduced mutations alter residues or
structures that are required for the interaction, or that the
CLV1yKAPP interaction is dependent on phosphorylation of
the CLV1 kinase domain. To see if this interaction was
dependent on the phosphorylation state of the CLV1 protein,
we treated GST-CKD with AP alone or with AP plus PO42
(PO42 is an inhibitor of the phosphatase). GST-KI had a
reduced interaction with the dephosphorylated GST-CKD as
compared with phosphorylated GST-CKD (Fig. 4A). This
interaction could be recovered by allowing the dephosphory-
lated GST-CKD protein to autophosphorylate (Fig. 4A).
The ability of the CLV1 kinase domain to phosphorylate
KAPP was also tested. The GST-CKD protein was able to
phosphorylate the full-length KAPP protein fused to GST
(Fig. 4B). Consistent with their abilities to autophosphorylate,
GST-CKD1-1 could phosphorylate GST-KAPP at reduced
levels and the GST-CKDK720E protein could not phosphorylate
GST-KAPP at any detectable level (Fig. 4B). GST-CKD
protein does not phosphorylate GST alone (data not shown).
The KAPP protein had previously been shown to have
protein phosphatase activity (12). To further investigate the
interaction between the CLV1 kinase domain and KAPP, we
tested KAPP’s ability to dephosphorylate GST-CKD in vitro.
The phosphorylated GST-CKD protein was incubated with the
GST-KAPP fusion protein in the presence and absence of
divalent cations. The CKD protein is dephosphorylated by
KAPP, and like other type 2C protein phosphatases, KAPP
activity is dependent on Mg21 andyor Mn21 (Fig. 4C).
DISCUSSION
We have started to investigate the molecular mechanisms of
CLV1 signal transduction. We have shown that the CLV1
kinase domain can undergo intermolecular autophosphoryla-
tion, which suggests that the active CLV1 protein may function
as a multimer. The KAPP protein binds the phosphorylated
form of CLV1 and exhibits phosphatase activity on the CLV1
protein. CLV1 is expressed in regions that also express KAPP,
although the KAPP expression domain is much larger. Finally,
transgenic plants overexpressing KAPP mimic the floral de-
fects seen in weak clv1 mutant plants. These data taken
together argue that KAPP may function as a negative regulator
of the CLV1 signal transduction pathway. A model for the
CLV1 signal transduction pathway is given in Fig. 5. Further
experimentation will be needed to test the in vivo validity of
FIG. 4. KAPP interactions with the CLV1 kinase domain. (A)
GST-KI protein was labeled at the heart muscle kinase site with
[g-32P]ATP and incubated with a filter containing immobilized GST-
CKD (lane 1), GST-CKD1-(lane 2), GST-CKDK720E (lane 3), GST-
CKD treated with AP (lane 4), GST-CKD treated with AP in the
presence of 100 mM PO42 (lane 5), and GST-CKD treated with AP,
then allowed to autophosphorylate in the presence of MnCl2 and ATP
(lane 6). (Upper) The Coomassie blue-stained gel showing the relative
amounts of fusion protein in each lane. (Lower) The autoradiograph.
(B) The GST-KAPP protein was incubated alone (lane 1) or with
GST-CKD (lane 2), GST-CKD1-(lane 3), or GST-CKDK720E (lane 4)
during an autophosphorylation reaction. Equal amounts of GST-CKD,
GST-CKD1-1, and GST-CKDK720E were added in each reaction. (C)
32P-labeled GST-CKD was incubated with full-length GST-KAPP
protein (lanes 1 and 2), or without GST-KAPP (lanes 3 and 4), and
with either MgCl2yMnCl2 (lanes 1 and 3) or EDTA (lanes 2 and 4).
Lane 5 is an untreated control. (Upper) Coomassie blue-stained gel
showing the approximately equal loading of GST-CKD in each lane.
(Lower) The autoradiogram.
FIG. 5. Model of CLV1 and KAPP Action. The model predicts that
CLV1, upon binding a peptide ligand, dimerizes and allows intermo-
lecular phosphorylation of the cytoplasmic kinase domains. The
activated receptor then binds and phosphorylates KAPP. The KAPP
protein may then modify the CLV1 signal by directly dephosphory-
lating CLV1. The CLV1 kinase domain probably interacts with other
positively acting components (X), which may or may not be dephos-
phorylated by KAPP. Based on epistasis analysis, WUS may function
downstream of CLV1 to promote cell divisions. SHOOTMERISTEM-
LESS may function independently but competitively with the CLV1
signaling pathway to promote cell division (24).
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this model, as the data are suggestive but not conclusive. In
particular, KAPP may function in a process parallel to CLV1.
Mechanisms of CLV1 Action. The CLV1 biochemical activ-
ity may account for the previously observed phenotype seen in
the clv1-1 mutant. The clv1-1 allele is predicted to encode a
full-length protein with a Gly-856 to aspartic acid missense
mutation in a conserved residue of subdomain VIII (9), which
is thought to be involved in the recognition of protein sub-
strates (21). clv1-1 homozygous plants have an intermediate
phenotype indicating that it is not a null allele. Also, clv1-1y1
heterozygous plants have a weak mutant phenotype (4, 7),
whereas the phenotypically stronger clv1-4 allele does not have
a heterozygous mutant phenotype, indicating that the CLV1-1
protein may act in a dominant negative manner. This suggests
that CLV1 may function as multimer.
The CLV1-1 form of the kinase domain can autophosphor-
ylate, but only at low levels, consistent with clv1-1 not being a
complete loss-of-function allele. We have also shown that the
CLV1 kinase domain can transphosphorylate an inactive form
of the protein. Furthermore, large amounts of the inactive
(CKDK720E) kinase can inhibit the autophosphorylation of the
wild-type protein. These data, consistent with the genetic data,
argue that the CLV1 protein may function as a multimer. Like
receptor-tyrosine kinases in animals (22), the CLV1 extracel-
lular domain may inhibit dimerization, which is overcome by
ligand binding. Upon oligomerization, the cytoplasmic do-
mains may autophosphorylate and then recruit specific down-
stream components.
We have also shown that CLV1 is capable of phosphorylat-
ing KAPP, but it remains to be seen if CLV1 phosphorylates
other substrates. As will be discussed below, KAPP is likely to
be a negative regulator of the CLV1 pathway. No downstream
components of the pathway have been identified, but epistasis
analysis suggests the product of the WUS (8) gene as a
candidate (Fig. 5).
Mechanisms of KAPP Action. Signaling pathways, like many
developmental mechanisms, need both positively acting com-
ponents and negative regulators. Positively acting components
are needed to transduce a signal to the nucleus for changes in
gene expression or to the cytoskeleton for changes in cell
shape. Negative regulators are needed to attenuate the sig-
naling cascade and to repress the pathway when the signal is
no longer present. The KAPP protein may function as a
negative regulator of the CLV1 signal transduction pathway.
The region of KAPP expression includes the CLV1 expression
domain, showing that the two genes are at least expressed in
the same cells. Moreover, high levels of KAPP gene expression
can mimic clv1 mutants. Mutations in the CLV1 or CLV3 genes
do not appear to affect the level of KAPP expression. So the
similarity of clv1 and 35S::KAPP phenotypes is probably not
the indirect result of increased KAPP expression in clv1 or clv3
plants.
More importantly, the KAPP protein binds to the phos-
phorylated form of the CLV1 kinase domain. The KAPP
protein does not appear to merely bind phosphoserine andyor
phosphothreonine, because KAPP does not interact with all
kinases tested (23), so there must be other sequence require-
ments for KAPP function. However, KAPP can bind to
denatured proteins and thus is not dependent on a proper
structural conformation (Fig. 4A; see also ref. 12), suggesting
that KAPP may recognize a short amino acid sequence.
Because the KAPP protein exhibits phosphatase activity to-
ward the CLV1 kinase domain, KAPP may function in vivo by
directly dephosphorylating CLV1, thus preventing other
downstream components from receiving the CLV1 signal.
KAPP may dephosphorylate other components of the pathway
as well. The KAPP protein is phosphorylated in the presence
of CLV1, suggesting that the activity of KAPP may be mod-
ulated in response to the activated CLV1 receptor. However,
our data suggest that phosphorylation of KAPP is not required
for KAPP to dephosphorylate CLV1.
Other Roles for KAPP. There are several lines of evidence
indicating that KAPP may function in a number of different
signaling pathways. First, KAPP interacts with RLK5, CLV1,
and several other receptor-like kinases (23). RLK5 and CLV1
are members of a large family of leucine-rich repeats contain-
ing receptor kinases, of which there are members in Arabi-
dopsis that are closely related to CLV1, and others closely
related to RLK5 (ref. 9; R.W.W. and E.M.M., unpublished
data). So far, no role has been ascribed to RLK5. Second,
based on low stringency hybridization experiments and ex-
pressed sequence tag database searches, there does not appear
to be another KAPP-like gene in the Arabidopsis genome
(R.W.W. and E.M.M., unpublished data). It is therefore
possible that KAPP is a promiscuous molecule that regulates
a number of signaling pathways.
The expression data for KAPP supports such an idea.
Previous work has shown that the KAPP mRNA is found in
root and rosette tissue (12). In situ hybridization to inflores-
cence tissue shows that KAPP is expressed throughout the
SAM and young floral primordia and in a punctate ring down
the stem. CLV1 is expressed in a much smaller region of the
SAM and floral meristems. Later in flower development,
KAPP is expressed in the pollen sacs and in the placenta and
ovules of the carpel, thus suggesting a role for KAPP in the
formation of gametes.
In the 35S::KAPP lines, we did not observe a defect in female
or male fertility. This may be due to higher endogenous levels
of KAPP mRNA in these cells andyor a very sensitive require-
ment for lower levels of KAPP mRNA in the CLV1-expressing
cells. Alternatively, the 35S promoter may not be active in
these cells. There were also minor floral organ identity defects
in the 35S::KAPP line, suggesting that KAPP can function in
CLV1 nonexpressing cells. The absence of observable defects
outside the flower indicates that KAPP overexpression does
not affect all cell types and likely needs other factors to
function. It is interesting to speculate that the relatively large,
and expanding family of leucine-rich repeat-kinases in plants
may play a variety of roles in communicating information
needed for proper cell proliferation, elongation, and differen-
tiation, and it is possible that KAPP may be an important
negative regulator of a number of these kinases.
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